文献速递小儿骨科

芬兰普遍临床筛查联合针对性超声筛查发育性髋关节发育不良有效

Universal Clinical DDH Screening Complemented with Targeted Ultrasound Is Effective in Finland.
PubMed 文献 · J Bone Joint Surg Am · 2025-02-20

该回顾性队列研究基于芬兰医疗保健登记数据,分析2002至2021年1103269名新生儿,评估普遍临床筛查联合针对性超声筛查项目下发育性髋关节发育不良(DDH)的发病率与晚诊断率,结论为该项目不劣于其他筛查方案。

要点

  • 20年间DDH平均发病率为5.8/1000新生儿(95%CI 5.7至6.0)。
  • 晚诊断病例平均发生率0.11/1000新生儿(95%CI 0.09至0.13)。
  • 芬兰现行普遍临床筛查联合针对性超声不劣于其他筛查方案。

核心结论

  • 芬兰现行DDH筛查方案(普遍临床筛查联合针对性超声)与其他筛查方案相比不劣。

研究设计与样本

  • 回顾性队列研究,基于芬兰医疗保健登记数据,收集2002至2021年15岁以下以DDH为主要诊断且就诊≥3次的儿童数据。

主要发现

  • 研究期间共出生1103269名婴儿,6421名儿童诊断为DDH,平均发病率5.8/1000新生儿(95%CI 5.7至6.0)。
  • 共120名6个月至<15岁儿童因DDH接受治疗,晚诊断平均发生率0.11/1000新生儿(95%CI 0.09至0.13)。
  • 晚诊断病例年际变化小(中位数6.5名,范围2至9名)。

关键数值与推荐

  • 晚诊断DDH定义为6个月至<15岁初诊时发现DDH且接受麻醉下治疗(闭合复位石膏固定或手术)。
  • 证据等级为预后III级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The late diagnosis rate of developmental dysplasia of the hip (DDH) with universal ultrasound screening is 0.2 per 1,000 children according to a recent meta-analysis, which is the same as in Japan where selective ultrasound screening is used. We hypothesized that Finland's current program of universal clinical screening complemented with targeted ultrasound is noninferior to universal and selective ultrasound screening programs. METHODS: For this retrospective cohort study, we collected the number of children <15 years of age who were diagnosed with DDH (International Classification of Diseases, Tenth Revision [ICD-10] codes Q65.0-Q65.6 and Ninth Revision [ICD-9] code 7543) as their primary diagnosis after ≥3 visits to a physician. These data were obtained from the Finnish Care Register for Health Care, which collects the ICD-10 and ICD-9 codes from every medical appointment. We calculated the annual incidence of DDH diagnoses per 1,000 newborns between 2002 and 2021. Late diagnosis of DDH was defined as a finding of DDH in children aged 6 months through <15 years at the initial diagnosis who had undergone treatment under anesthesia (closed reduction and casting or surgery). We also registered the geographic, age, and sex distributions of the DDH diagnoses. RESULTS: During the 20-year study period, 1,103,269 babies were born (median per year, 57,214 babies; range per year, 45,346 to 60,694 babies). A total of 6,421 children had a diagnosis of DDH (mean per year, 321 children; range per year, 193 to 405 children), with a mean calculated incidence of 5.8 per 1,000 newborns (95% confidence interval [CI], 5.7 to 6.0). Altogether, 120 children aged 6 months through <15 years were treated for DDH, with little annual variation (median, 6.5 children; range, 2 to 9 children). The mean national incidence of late-diagnosed cases was 0.11 per 1,000 newborns (95% CI, 0.09 to 0.13). CONCLUSIONS: Finland's current DDH screening program, which includes universal clinical screening with targeted ultrasound, is noninferior when compared with other screening programs. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Luoto ES, Jalkanen J, Kuitunen I, et al. Universal Clinical DDH Screening Complemented with Targeted Ultrasound Is Effective in Finland. J Bone Joint Surg Am. 2025. PMID: 39977488. doi:10.2106/JBJS.24.00313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。